Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.3909
+0.0008 (0.21%)
At close: Sep 1, 2026, 4:00 PM EDT
0.3899
-0.0010 (-0.26%)
After-hours: Sep 1, 2026, 7:57 PM EDT

Mangoceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.320.460.620.730.01-
Revenue Growth
-38.91%-25.96%-15.81%8083.16%--
Gross Profit
0.170.250.380.430-
Operating Income
-13.43-17.59-8.24-8.12-1.99-0.07
Net Income
-16.57-21.82-9.51-9.21-2-0.07
Earnings Per Share
-1.12-2.17-4.80-8.58-2.78-
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.231.490.060.740.680.02
Total Debt
0.280.310.210.130.350.04
Net Cash (Debt)
-0.051.18-0.160.610.33-0.02
Net Cash Growth
---84.95%--
Net Cash Per Share
-0.000.12-0.080.570.46-0.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.89-5.85-4.86-7-1.35-0.07
Capital Expenditures
----0-0.04-
Free Cash Flow
-3.89-5.85-4.86-7-1.39-0.07
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.43%54.91%61.70%58.99%54.26%-
Operating Margin
-4261.46%-3858.11%-1337.90%-1109.84%-22279.70%-
Pretax Margin
-4791.54%-4526.86%-1413.80%-1259.40%-22352.11%-
Profit Margin
-5257.67%-4784.65%-1543.87%-1259.40%-22352.11%-
FCF Margin
-1234.31%-1282.89%-789.74%-957.07%-15545.59%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.2924.9710.077.96--